[1. DeSantis CE, Lin LC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252-71.10.3322/caac.2123524890451]Search in Google Scholar
[2. Raeisi E, Aghamiri SM, Bandi A, Rahmatpour N, Firoozabadi SM, Kafi-Abad SA, et al. The antitumor efficiency of combined electrochemotherapy and single dose irradiation on a breast cancer tumor model. Radiol Oncol. 2012;46(3):226-32.10.2478/v10019-012-0035-x347294723077461]Search in Google Scholar
[3. Pérez-Herrero E, Fernández-Medarde A. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 2015;93:52-79.10.1016/j.ejpb.2015.03.01825813885]Search in Google Scholar
[4. Ghosh S. Cisplatin: The first metal based anticancer drug. Bioorg Chem. 2019;88:102925.10.1016/j.bioorg.2019.10292531003078]Search in Google Scholar
[5. Damia G, Broggini M. Platinum resistance in ovarian cancer: Role of DNA repair. Cancers (Basel). 2019;11(1):119.10.3390/cancers11010119635712730669514]Search in Google Scholar
[6. Maehara Y, Oki E, Saeki H, Tokunaga E, Kitao H, Iimori M, et al. Evolving 5-fluorouracil therapy to achieve enhanced efficacy-past and current efforts of researchers. Gan To Kagaku Ryoho. 2016; 43(7):845-54.]Search in Google Scholar
[7. Sun W, Sanderson P, Zheng W. Drug combination therapy increases successful drug repositioning. Drug Discov Today. 2016;21(7): 1189-95.10.1016/j.drudis.2016.05.015490786627240777]Search in Google Scholar
[8. Rathnavelu V, Alitheen N, Sohila S, Kanagesan S, Ramesh R. Potential role of bromelain in clinical and therapeutic applications. Biomed Rep. 2016;5(3):283-8.10.3892/br.2016.720499815627602208]Search in Google Scholar
[9. Satari A, Amini AS, Raeisi E, Lemoigne Y, Hiedarian E. Synergetic impact of combined 5-fluorouracil and rutin on apoptosis in pc3 cancer cells through the modulation of p53 gene expression. Adv Pharm Bull. 2019;9(3):462-9.10.15171/apb.2019.055677393931592435]Search in Google Scholar
[10. Pauzi AZ, Yeap S, Abu N, Lim KL, Omar AR, Aziz SA, et al. Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro. Chin Med. 2016;11:46.10.1186/s13020-016-0118-5511126427891174]Search in Google Scholar
[11. Raeisi F, Shahbazi-Gahrouei D, Raeisi E, Heidarian E. Evaluation of the radiosensitizing potency of bromelain for radiation therapy of 4t1 breast cancer cells. J Med Signals Sens. 2019;9(1):68-74.10.4103/jmss.JMSS_25_18641956430967992]Search in Google Scholar
[12. Amini A, Masoumi-Moghaddam S, Ehteda A, Morris DL. Bromelain and n-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: Significance of combination therapy. J Exp Clin Cancer Res. 2014;33(1):92.]Search in Google Scholar
[13. Amini A, Masoumi-Moghaddam S, Ehteda A, Liauw W, Morris DL. Potentiation of chemotherapeutics by bromelain and n-acetylcysteine: Sequential and combination therapy of gastrointestinal cancer cells. Am J Cancer Res. 2016;6(2):350-69.]Search in Google Scholar
[14. Müller A, Barat S, Chen X, Bui KC, Bozko P, Malek NP, et al. Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines. Int J Oncol. 2016;48(5): 2025-34.10.3892/ijo.2016.341126935541]Search in Google Scholar
[15. Pillai K, Ehteda A, Akhter J, Chua TC, Morris DL. Anticancer effect of bromelain with and without cisplatin or 5-fu on malignant peritoneal mesothelioma cells. Anticancer Drugs. 2014;25(2):150-60.10.1097/CAD.000000000000003924366282]Search in Google Scholar